Joint pain is not a listed side effect of semaglutide on its FDA-approved labeling. The official adverse reaction profile for Wegovy (the weight-loss formulation) includes gastrointestinal symptoms like nausea, diarrhea, vomiting, and constipation at rates of 5% or higher, but arthralgia or musculoskeletal pain does not appear among them. That said, some people taking semaglutide do report new or worsening joint discomfort, and there are plausible indirect reasons why.
What the Clinical Trials Actually Show
Large-scale trials of semaglutide have not flagged joint pain as a significant side effect. In fact, the strongest clinical evidence points in the opposite direction. A trial published in the New England Journal of Medicine studied people with obesity and moderate knee osteoarthritis who took semaglutide 2.4 mg weekly for 68 weeks. Their pain scores dropped by 41.7 points on a 100-point scale, compared to 27.5 points in the placebo group. Physical function scores also improved nearly twice as much with semaglutide as with placebo.
This makes intuitive sense. Excess weight puts enormous mechanical stress on joints, especially the knees and hips. Every pound of body weight translates to roughly four pounds of force across the knee during walking. Losing 15% or more of body weight, as many participants in semaglutide trials do, can meaningfully reduce that load. Beyond the mechanical relief, fat tissue itself produces inflammatory signals that contribute to joint breakdown and pain. Reducing fat mass lowers those signals throughout the body.
Why Some People Still Report Joint Pain
If the drug itself doesn’t cause joint pain, why do some users experience it? Several indirect mechanisms are worth understanding.
Rapid weight loss from any cause tends to reduce muscle mass along with fat. Semaglutide users can lose a meaningful percentage of their lean body mass, particularly if they aren’t doing resistance exercise or eating enough protein. Muscles act as shock absorbers and stabilizers for your joints. When they shrink, joints absorb more impact during everyday movement, which can lead to new aches, especially in the knees, hips, and lower back.
Dehydration is another factor. The most common side effects of semaglutide are nausea, vomiting, and diarrhea, all of which can leave you chronically under-hydrated if you’re not deliberately drinking more water. Joint cartilage depends on adequate hydration to stay cushioned and pliable. Even mild, persistent dehydration can make joints feel stiff and sore.
There’s also a subtler possibility: people who lose significant weight often become more physically active. If your joints weren’t accustomed to regular walking, hiking, or gym workouts, ramping up activity can produce aches that feel like a drug side effect but are really an exercise adaptation issue.
How Semaglutide Compares to Similar Drugs
A large analysis of over 60,000 social media posts about GLP-1 medications found that joint pain was mentioned with semaglutide-based drugs, but far less often than with tirzepatide (sold as Mounjaro and Zepbound). Posts about tirzepatide mentioned joint pain more than twice as frequently as posts about semaglutide. For tirzepatide users, joint pain and headaches were actually discussed more often than the typical gastrointestinal complaints. This doesn’t prove tirzepatide causes more joint issues, since social media reports aren’t controlled data, but it does suggest joint pain is not a particularly prominent concern among semaglutide users relative to the broader drug class.
Reducing Joint Discomfort While on Semaglutide
If you’re experiencing joint pain after starting semaglutide, a few practical steps can help identify and address the cause.
- Prioritize protein and resistance training. Preserving muscle mass is the single most important thing you can do for your joints during weight loss. Aim for strength training at least two to three times per week, focusing on the muscles around whichever joints bother you most. Higher protein intake (around 1 gram per kilogram of your goal body weight daily) supports muscle retention.
- Stay hydrated throughout the day. This is especially important if you’re experiencing nausea or GI side effects. Sipping water consistently, rather than trying to drink large amounts at once, tends to work better when appetite is suppressed.
- Increase activity gradually. If you’ve become more active since starting the medication, make sure you’re giving your joints time to adapt. Sudden jumps in walking distance or workout intensity are a common trigger for knee and hip pain.
- Track the timing. Note whether the pain started with semaglutide itself, with a dose increase, or with a change in your activity level. This information helps distinguish a drug-related effect from a lifestyle-related one.
The Bigger Picture on Joint Health
For most people with obesity, semaglutide is more likely to improve joint pain than cause it. The NEJM osteoarthritis trial is the clearest evidence of this: participants experienced clinically meaningful pain relief that went well beyond what weight loss alone would predict, suggesting the drug’s anti-inflammatory properties may play an additional role. Joint pain that does appear during treatment is more commonly a byproduct of rapid body composition changes or increased activity than a direct pharmacological effect.
If joint pain is severe, worsening, or accompanied by swelling and redness in a specific joint, that warrants medical evaluation regardless of whether you’re taking semaglutide. Those symptoms can indicate conditions like gout or inflammatory arthritis that require their own treatment and happen to coincide with starting a new medication.